Covetrus Inc. (CVET): Price and Financial Metrics


Covetrus Inc. (CVET): $20.99

0.06 (+0.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CVET POWR Grades

  • CVET scores best on the Growth dimension, with a Growth rank ahead of 99.72% of US stocks.
  • CVET's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • CVET ranks lowest in Momentum; there it ranks in the 9th percentile.

CVET Stock Summary

  • CVET's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 215.11 -- higher than 89.09% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for CVET is currently 45.77, higher than 91.17% of US stocks with positive operating cash flow.
  • Of note is the ratio of COVETRUS INC's sales and general administrative expense to its total operating expenses; 86.61% of US stocks have a lower such ratio.
  • If you're looking for stocks that are quantitatively similar to COVETRUS INC, a group of peers worth examining would be LWAY, HCDI, NEGG, INFU, and KRUS.
  • Visit CVET's SEC page to see the company's official filings. To visit the company's web site, go to www.covetrus.com.

CVET Valuation Summary

  • In comparison to the median Technology stock, CVET's price/sales ratio is 75% lower, now standing at 0.6.
  • CVET's price/sales ratio has moved down 0.6 over the prior 45 months.

Below are key valuation metrics over time for CVET.

Stock Date P/S P/B P/E EV/EBIT
CVET 2022-10-07 0.6 1.9 -224.8 1942.3
CVET 2022-10-06 0.6 1.9 -225.0 1943.7
CVET 2022-10-05 0.6 1.9 -225.0 1943.7
CVET 2022-10-04 0.6 1.9 -225.0 1943.7
CVET 2022-10-03 0.6 1.9 -225.1 1944.4
CVET 2022-09-30 0.6 1.9 -224.8 1942.3

CVET's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CVET has a Quality Grade of D, ranking ahead of 19.59% of graded US stocks.
  • CVET's asset turnover comes in at 1.31 -- ranking 102nd of 165 Retail stocks.
  • 500 - Internal server error

The table below shows CVET's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.310 0.184 -0.022
2021-03-31 1.253 0.184 0.022
2020-12-31 1.238 0.184 0.011
2020-09-30 1.217 0.181 0.004
2020-06-30 1.202 0.185 -0.489
2020-03-31 1.142 0.188 -0.520

CVET Price Target

For more insight on analysts targets of CVET, see our CVET price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.83 Average Broker Recommendation 1.5 (Moderate Buy)

CVET Stock Price Chart Interactive Chart >

Price chart for CVET

CVET Price/Volume Stats

Current price $20.99 52-week high $21.20
Prev. close $20.93 52-week low $13.39
Day low $20.93 Volume 5,301,000
Day high $21.00 Avg. volume 1,343,024
50-day MA $20.86 Dividend yield N/A
200-day MA $18.83 Market Cap 2.94B

Covetrus Inc. (CVET) Company Bio


Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.


CVET Latest News Stream


Event/Time News Detail
Loading, please wait...

CVET Latest Social Stream


Loading social stream, please wait...

View Full CVET Social Stream

Latest CVET News From Around the Web

Below are the latest news stories about COVETRUS INC that investors may wish to consider to help them evaluate CVET as an investment opportunity.

Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600

Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18. Clayton, Dubilier & Rice and TPG Capital acquired Covetrus in a deal that closed today. MillerKnoll is more representative of the small-cap market space.

Yahoo | October 13, 2022

Covetrus Names Michelle Bonfilio as Chief People Officer

PORTLAND, Maine, September 26, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company.

Yahoo | September 26, 2022

Moody's assigns B2 CFR to Covetrus, Inc.; Outlook Stable

The ratings are being assigned in conjunction with a leveraged buyout of the company. Moody's also assigned B1 ratings to the company's proposed first-lien credit facilities, consisting of a $300 million bank revolving credit facility expiring 2027, and a $1,525 million term loan due 2029.

Yahoo | September 7, 2022

Covetrus Names Margie B. Pritchard General Counsel

PORTLAND, Maine, August 26, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus.

Yahoo | August 26, 2022

Covetrus Announces Retirement of Matthew Foulston

PORTLAND, Maine, August 11, 2022--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Matthew Foulston, the Company’s Executive Vice President and Chief Financial Officer, has informed the company that he will be retiring from the company effective December 31, 2022.

Yahoo | August 11, 2022

Read More 'CVET' Stories Here

CVET Price Returns

1-mo N/A
3-mo 0.43%
6-mo 1.40%
1-year 11.83%
3-year 54.91%
5-year N/A
YTD 5.11%
2021 -30.51%
2020 117.73%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6377 seconds.